Document is current

Article History

Received: 4 December 2024

Accepted: 24 April 2025

First Online: 14 May 2025

Competing interests

: R.J.A.F. reports grants and non-financial support from Personal Genome Diagnostics, non-financial support from Delfi Diagnostics, grants from MERCK BV, grants and non-financial support from Cergentis BV, outside the submitted work. In addition, R.J.A.F. has several patents pending. S.A. reports grants and non-financial support from Cergentis BV, Olink, Quanterix, and a patent pending, outside the submitted work. S.L. reports non-financial support from Cergentis BV and a patent pending, outside the submitted work. R.W. reports non-financial support from Cergentis BV. J.H. reports a patent pending, outside the submitted work. G.A.M. is co-founder and board member (CSO) of CRCbioscreen BV, CSO of Health-RI (Dutch National Health Data Infrastructure for Research & Innovation), and member of the supervisory board of IKNL (Netherlands Comprehensive Cancer Organisation). G.A.M. non-financial support from Exact Sciences, non-financial support from Sysmex, non-financial support from Sentinel CH. SpA, non-financial support from Personal Genome Diagnostics (PGDX), non-financial support from DELFI, other from Hartwig Medical Foundation, grants from CZ (OWM Centrale Zorgverzekeraars groep Zorgverzekeraar u.a), other from Royal Philips, other from GlaxoSmithKline, other from Keosys SARL, other from Open Clinica LLC, other from Roche Diagnostics Nederland BV, other from The Hyve BV, other from Open Text, other from SURFSara BV, other from Vancis BV, other from CSC Computer Sciences BV, outside the submitted work; In addition, G.A.M. has several patents pending. The other authors declare no potential competing interests.